Suchergebnisse - "Corso, Alessandro"

PubPharm (5)

1

Secondary infections worsen the outcome of COVID-19 in patients with hematological malignancies : A report from the ITA-HEMA-COV

enthalten in: Hematological oncology | 2022

von Zappasodi, P. | Cattaneo, C. | Valeria Ferretti, V. | +52

2

A prognostic model for patients with lymphoma and COVID-19 : a multicentre cohort study

enthalten in: Blood advances | 2022

von Visco, C. | Marcheselli, L. | Mina, R. | +55

ErratumIn: Blood Adv. 2023 Mar 28;7(6):1065. - PMID 36943316

3

Secondary infections worsen the outcome of COVID‐19 in patients with hematological malignancies : A report from the ITA‐HEMA‐COV

enthalten in: Hematological Oncology | 2022

von Zappasodi, P. | Cattaneo, C. | Valeria Ferretti, V. | +51

4

COVID-19 elicits an impaired antibody response against SARS-CoV-2 in patients with haematological malignancies

enthalten in: British journal of haematology | 2021

von Passamonti, F. | Romano, A. | Salvini, M. | +52

5

Clinical characteristics and risk factors associated with COVID-19 severity in patients with haematological malignancies in Italy : a retrospective, multicentre, cohort study

enthalten in: The Lancet. Haematology | 2020

von Passamonti, F. | Cattaneo, C. | Arcaini, L. | +72

CommentIn: Lancet Haematol. 2020 Oct;7(10):e701-e703. - PMID 32798474

1
[1]